Developer docs
API playgroundTry for free, no card

Search company profiles

EMMA International Consulting Group

Full company profile

uuid0007iau

Namestring
EMMA International Consulting Group
Legal namestring
E.M.M.A. International Consulting Group, Inc.
Company typeenum
Private
Founded yearint
2013
Descriptiontext

EMMA International Consulting Group, Inc. is a privately held global consulting firm headquartered in Birmingham, Michigan, founded in 2013 and specializing in regulatory compliance, quality management, and operational excellence advisory for organizations in highly regulated industries. Its core client base spans three primary verticals: Life Sciences (pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, and combination products), Healthcare Systems (hospitals, clinical laboratories, telehealth providers), and Technology/AI/FinTech. Named enterprise customers include Pfizer, Inertia Product Development, and New Concept Technology, alongside undisclosed pharmaceutical clients served through staff-augmentation engagements.

The firm delivers services through an integrated "EMMA Advantage" model that bundles advisory, operational, and implementation capabilities under a single-partner engagement, covering global regulatory and compliance advisory, enterprise quality and risk management, remediation and crisis support, operational excellence, and staff augmentation. Recent product launches include AI Solutions (January 2026) for life sciences AI deployment under regulatory frameworks, and Financial Services for Life Sciences Companies (October 2025). The company operates a franchise program and a "Global Consultant Community" of subject-matter experts that enables rapid scaling of engagements, including two-week site staffing during remediation surges.

EMMA International generates revenue through professional services engagements with custom, quote-based pricing, sourced primarily via direct website contact and phone outreach (no public pricing). Distribution is consultative and enterprise-led across North America, Europe, Asia-Pacific, and the Middle East. The firm is a WBENC-certified Women-Owned Business Enterprise and DisabilityIN DOBE-certified, holds ISO 9001:2015 certification, and received the EurAsia Gulf Excellence Award in December 2025. Its January 2026 acquisition of QualityMed Consulting Partners LLC extends healthcare quality and accreditation capabilities, while its February 2026 introduction of cryptocurrency payment acceptance signals commercial-channel experimentation.

Short descriptiontext

EMMA International Consulting Group is a privately held, Birmingham, Michigan-based global consulting firm providing FDA/EMA regulatory compliance, quality management, and operational excellence advisory to life sciences, healthcare systems, and technology/AI/FinTech clients worldwide through an integrated single-partner model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMichigan, United States
HQ citystring
Michigan
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
regulatory compliance consulting, FDA regulatory affairs, quality management systems, life sciences consulting, medical device compliance
Industry1 code
1Strategy & IT Advisory
CodeBPAEAAAAPrimaryYes
NAICS code1 code
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Regulatory Compliance Consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Regulatory and Compliance Consulting Services
TypeProfessional Services
Description

EMMA International generates revenue through professional consulting services focused on regulatory compliance, quality management, and operational excellence for regulated industries including life sciences, healthcare systems, and technology/AI/FinTech sectors. Services include regulatory strategy, quality system implementation, remediation, and inspection readiness support.

emmainternational.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components3 values
Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

EMMA International is a global consulting firm that provides integrated regulatory, quality, and operational advisory services to organizations operating in complex and regulated environments. The firm delivers end-to-end consulting under 'The EMMA Advantage' model—combining advisory, operational, and implementation capabilities across life sciences, healthcare systems, manufacturing, aerospace & defense, government, and technology/AI/FinTech sectors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

EMMA International Consulting Group is a global consulting firm providing integrated advisory, regulatory, quality, and operational consulting services. The company operates across three primary sectors: Life Sciences (pharmaceuticals, biotech, medical devices), Healthcare Systems, and Technology/AI/FinTech. Core offerings include Global Regulatory & Compliance Advisory, Enterprise Quality & Risk Management, Remediation & Crisis Support, and Operational Excellence & Performance Improvement. The company recently launched AI Solutions for life sciences and Financial Services for life sciences companies. EMMA delivers services through 'The EMMA Advantage' model—an integrated, end-to-end consulting approach under a single partner that combines advisory, operational, and implementation capabilities. Recent expansion includes the acquisition of QualityMed Consulting Partners LLC to enhance healthcare quality improvement and accreditation preparation services.

Product and service9 records
1Life Sciences Consulting
CategoryVertical Practice Area
2Healthcare Systems Consulting
CategoryVertical Practice Area
3Technology, AI & FinTech Consulting
CategoryVertical Practice Area
4Global Regulatory & Compliance Advisory
CategoryRegulatory Services
5Enterprise Quality & Risk Management
CategoryQuality & Risk Management
6Remediation & Crisis Support
CategoryRemediation & Crisis Support
7Operational Excellence & Performance Improvement
CategoryOperational Excellence
8AI Solutions
CategoryNew Consulting Service
9Financial Services for Life Sciences Companies
CategoryNew Consulting Service
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-29
Description

EMMA International acquired QualityMed Consulting Partners LLC, a healthcare consulting firm headquartered in Washington, D.C. specializing in quality improvement, accreditation preparation (TJC, JCI, CAP), and strategic planning. The acquisition combines EMMA's global regulatory and compliance expertise with QualityMed's healthcare quality capabilities to deliver an expanded suite of services to healthcare and life sciences organizations worldwide. QualityMed CEO Sammy Alnajm and EMMA International CEO Carmine Jabri highlighted the strategic value of combining complementary capabilities to accelerate their shared mission of improving healthcare quality and patient outcomes on a global scale.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

ProPharma Group is a regulatory, compliance, and quality consulting firm serving pharmaceutical, medical device, and biotech companies — directly comparable to EMMA's life-sciences regulatory and quality management core.

TypeDirect peer
Description

RQM+ is a medical-device-focused regulatory and quality consulting firm offering FDA submissions, ISO 13485, EU MDR, and remediation services — directly overlapping EMMA's medical-device regulatory practice.

TypeBroad incumbent
Description

ICON is a global CRO with a regulatory and clinical consulting practice serving pharma and biotech. It is a much larger incumbent but competes for the same regulatory-affairs and quality engagements as EMMA.

TypeBroad incumbent
Description

Parexel is a global CRO with extensive regulatory consulting and market access services for biopharma — broader scale incumbent with significant overlap to EMMA's global regulatory advisory offerings.

TypeBroad incumbent
Description

IQVIA is the largest global life-sciences services firm, offering regulatory affairs, quality, and compliance consulting alongside its broader clinical and data offerings — a broad incumbent competing for enterprise regulatory engagements.

TypeDirect peer
Description

PharmaLex (now part of Cencora/Alliance Healthcare) is a regulatory affairs and pharmacovigilance consulting firm serving life-sciences clients — directly comparable to EMMA's regulatory strategy, submissions, and compliance practice.

TypeDirect peer
Description

NSF's Health Sciences division provides regulatory consulting, quality system implementation, and ISO certification services for medical devices, pharma, and biotech — directly comparable to EMMA's quality management and ISO consulting.

TypeDirect peer
Description

MakroCare is a clinical research and regulatory consulting firm serving pharma, biotech, and medical-device companies globally — closely aligned with EMMA's regulatory strategy and submissions focus.

TypeEmerging player
Description

BioAgilytix is a bioanalytical and biomarker services firm that has expanded into regulatory and quality consulting support for early-stage biotech — partial overlap with EMMA's biotech regulatory work.

TypeBroad incumbent
Description

Charles River Laboratories is a large life-sciences services firm with regulatory, quality, and manufacturing-support consulting capabilities — broad incumbent overlapping with EMMA's pharma and medical-device practice.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

EMMA International Consulting Group

Regulatory Compliance Consultingemmainternational.com

EMMA International Consulting Group is a privately held, Birmingham, Michigan-based global consulting firm providing FDA/EMA regulatory compliance, quality management, and operational excellence advisory to life sciences, healthcare systems, and technology/AI/FinTech clients worldwide through an integrated single-partner model.

What EMMA International Consulting Group does

EMMA International Consulting Group, Inc. is a privately held global consulting firm headquartered in Birmingham, Michigan, founded in 2013 and specializing in regulatory compliance, quality management, and operational excellence advisory for organizations in highly regulated industries. Its core client base spans three primary verticals: Life Sciences (pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, and combination products), Healthcare Systems (hospitals, clinical laboratories, telehealth providers), and Technology/AI/FinTech. Named enterprise customers include Pfizer, Inertia Product Development, and New Concept Technology, alongside undisclosed pharmaceutical clients served through staff-augmentation engagements.

The firm delivers services through an integrated "EMMA Advantage" model that bundles advisory, operational, and implementation capabilities under a single-partner engagement, covering global regulatory and compliance advisory, enterprise quality and risk management, remediation and crisis support, operational excellence, and staff augmentation. Recent product launches include AI Solutions (January 2026) for life sciences AI deployment under regulatory frameworks, and Financial Services for Life Sciences Companies (October 2025). The company operates a franchise program and a "Global Consultant Community" of subject-matter experts that enables rapid scaling of engagements, including two-week site staffing during remediation surges.

EMMA International generates revenue through professional services engagements with custom, quote-based pricing, sourced primarily via direct website contact and phone outreach (no public pricing). Distribution is consultative and enterprise-led across North America, Europe, Asia-Pacific, and the Middle East. The firm is a WBENC-certified Women-Owned Business Enterprise and DisabilityIN DOBE-certified, holds ISO 9001:2015 certification, and received the EurAsia Gulf Excellence Award in December 2025. Its January 2026 acquisition of QualityMed Consulting Partners LLC extends healthcare quality and accreditation capabilities, while its February 2026 introduction of cryptocurrency payment acceptance signals commercial-channel experimentation.

EMMA International Consulting Group firmographics

Firmographics
Name
EMMA International Consulting Group
Legal name
E.M.M.A. International Consulting Group, Inc.
Website
https://emmainternational.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
51–100 employees
Short description
EMMA International Consulting Group is a privately held, Birmingham, Michigan-based global consulting firm providing FDA/EMA regulatory compliance, quality management, and operational excellence advisory to life sciences, healthcare systems, and technology/AI/FinTech clients worldwide through an integrated single-partner model.
Ownership category
akta.pro rank

EMMA International Consulting Group industry classification

Industry
Product category
Regulatory Compliance Consulting
NAICS
Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro primary industry
Strategy & IT Advisory (BPAEAAAA)

Keywords

  • Regulatory compliance consulting
  • FDA regulatory affairs
  • Quality management systems
  • Life sciences consulting
  • Medical device compliance

Where EMMA International Consulting Group is headquartered

Location

Headquarters

HQ city
Michigan
HQ country
United States
HQ region
North America

Offices1 record

Markets served

EMMA International Consulting Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales

Revenue model

  1. Regulatory and Compliance Consulting Services: EMMA International generates revenue through professional consulting services focused on regulatory compliance, quality management, and operational excellence for regulated industries including life sciences, healthcare systems, and technology/AI/FinTech sectors. Services include regulatory strategy, quality system implementation, remediation, and inspection readiness support.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

EMMA International Consulting Group product offering

Product offering

Core offering

EMMA International is a global consulting firm that provides integrated regulatory, quality, and operational advisory services to organizations operating in complex and regulated environments. The firm delivers end-to-end consulting under 'The EMMA Advantage' model—combining advisory, operational, and implementation capabilities across life sciences, healthcare systems, manufacturing, aerospace & defense, government, and technology/AI/FinTech sectors.

Product overview

EMMA International Consulting Group is a global consulting firm providing integrated advisory, regulatory, quality, and operational consulting services. The company operates across three primary sectors: Life Sciences (pharmaceuticals, biotech, medical devices), Healthcare Systems, and Technology/AI/FinTech. Core offerings include Global Regulatory & Compliance Advisory, Enterprise Quality & Risk Management, Remediation & Crisis Support, and Operational Excellence & Performance Improvement. The company recently launched AI Solutions for life sciences and Financial Services for life sciences companies. EMMA delivers services through 'The EMMA Advantage' model—an integrated, end-to-end consulting approach under a single partner that combines advisory, operational, and implementation capabilities. Recent expansion includes the acquisition of QualityMed Consulting Partners LLC to enhance healthcare quality improvement and accreditation preparation services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Life Sciences Consulting
  • Healthcare Systems Consulting
  • Technology, AI & FinTech Consulting
  • Global Regulatory & Compliance Advisory
  • Enterprise Quality & Risk Management
  • Remediation & Crisis Support
  • Operational Excellence & Performance Improvement
  • AI Solutions
  • Financial Services for Life Sciences Companies

Companies that use EMMA International Consulting Group

Customer profile

Named customers5 records

Segments6 records

Ideal customer profiles4 records

EMMA International Consulting Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

EMMA International Consulting Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • QualityMed Consulting Partners LLCcoreStrategic or Co-development Partner · 29 January 2026EMMA International acquired QualityMed Consulting Partners LLC, a healthcare consulting firm headquartered in Washington, D.C. specializing in quality improvement, accreditation preparation (TJC, JCI, CAP), and strategic planning. The acquisition combines EMMA's global regulatory and compliance expertise with QualityMed's healthcare quality capabilities to deliver an expanded suite of services to healthcare and life sciences organizations worldwide. QualityMed CEO Sammy Alnajm and EMMA International CEO Carmine Jabri highlighted the strategic value of combining complementary capabilities to accelerate their shared mission of improving healthcare quality and patient outcomes on a global scale.

Scale indicators1 record

Recent moves5 records

Expansion highlights7 records

EMMA International Consulting Group competitors and assessment

Company assessment

Direct peers

  • ProPharma Group: ProPharma Group is a regulatory, compliance, and quality consulting firm serving pharmaceutical, medical device, and biotech companies — directly comparable to EMMA's life-sciences regulatory and quality management core.
  • RQM+: RQM+ is a medical-device-focused regulatory and quality consulting firm offering FDA submissions, ISO 13485, EU MDR, and remediation services — directly overlapping EMMA's medical-device regulatory practice.
  • PharmaLex (Cencora): PharmaLex (now part of Cencora/Alliance Healthcare) is a regulatory affairs and pharmacovigilance consulting firm serving life-sciences clients — directly comparable to EMMA's regulatory strategy, submissions, and compliance practice.
  • NSF (Health Sciences): NSF's Health Sciences division provides regulatory consulting, quality system implementation, and ISO certification services for medical devices, pharma, and biotech — directly comparable to EMMA's quality management and ISO consulting.
  • MakroCare: MakroCare is a clinical research and regulatory consulting firm serving pharma, biotech, and medical-device companies globally — closely aligned with EMMA's regulatory strategy and submissions focus.

Broad incumbents

  • ICON plc: ICON is a global CRO with a regulatory and clinical consulting practice serving pharma and biotech. It is a much larger incumbent but competes for the same regulatory-affairs and quality engagements as EMMA.
  • Parexel International: Parexel is a global CRO with extensive regulatory consulting and market access services for biopharma — broader scale incumbent with significant overlap to EMMA's global regulatory advisory offerings.
  • IQVIA: IQVIA is the largest global life-sciences services firm, offering regulatory affairs, quality, and compliance consulting alongside its broader clinical and data offerings — a broad incumbent competing for enterprise regulatory engagements.
  • Charles River Laboratories: Charles River Laboratories is a large life-sciences services firm with regulatory, quality, and manufacturing-support consulting capabilities — broad incumbent overlapping with EMMA's pharma and medical-device practice.

Emerging players

  • BioAgilytix Labs: BioAgilytix is a bioanalytical and biomarker services firm that has expanded into regulatory and quality consulting support for early-stage biotech — partial overlap with EMMA's biotech regulatory work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

EMMA International Consulting Group social profiles

Digital presence

EMMA International Consulting Group compliance and trust

Trust signal

Compliance3 records

EMMA International Consulting Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

EMMA International Consulting Group leadership team

Management profile

Number of profiles

Profiles2 records

EMMA International Consulting Group subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

EMMA International Consulting Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

EMMA International Consulting Group M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EMMA International Consulting Group

What does EMMA International Consulting Group do?

EMMA International is a global consulting firm that provides integrated regulatory, quality, and operational advisory services to organizations operating in complex and regulated environments. The firm delivers end-to-end consulting under 'The EMMA Advantage' model—combining advisory, operational, and implementation capabilities across life sciences, healthcare systems, manufacturing, aerospace & defense, government, and technology/AI/FinTech sectors.

Is EMMA International Consulting Group a public or private company?

EMMA International Consulting Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was EMMA International Consulting Group founded?

EMMA International Consulting Group was founded in 2013. It employs 51 to 100 people.

Where is EMMA International Consulting Group based?

EMMA International Consulting Group is headquartered in Michigan, United States, in the North America region.

How does EMMA International Consulting Group make money?

One revenue line is on record: regulatory and Compliance Consulting Services.

Who are EMMA International Consulting Group's main competitors?

Direct peers on record are ProPharma Group, RQM+, PharmaLex (Cencora), NSF (Health Sciences) and MakroCare. Broad incumbents are ICON plc, Parexel International, IQVIA and Charles River Laboratories. BioAgilytix Labs is listed as an emerging player.

Does EMMA International Consulting Group have an API?

No public API is recorded for EMMA International Consulting Group.

What industry is EMMA International Consulting Group in?

EMMA International Consulting Group's product category is Regulatory Compliance Consulting. Its primary akta.pro industry code is BPAEAAAA, Strategy & IT Advisory. Its NAICS code is 541618 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireEMMA International Welcomes Jacob Griesbach as Business Development SpecialistJacob Griesbach joined EMMA International as Business Development Specialist, bringing healthcare sales and business development experience across pharmaceutical, biologics, and medical device industries. He will oversee strategies to enhance revenue streams, foster partnerships, and drive business development initiatives. The addition supports EMMA International's expansion across the life sciences industry.EIN PresswireEMMA International Appoints Brian La Cour as Director of Franchise GrowthEMMA International appointed Brian La Cour as Director of Franchise Growth, bringing over 20 years of franchise development and operational leadership experience. The role will lead operational strategy and support the growth of EMMA's franchise network, aiming to build scalable infrastructure and strengthen franchisee support.EIN PresswireEMMA International Relocates Global Headquarters to Miami, FloridaEMMA International is relocating its global headquarters from Birmingham, Michigan to Miami, Florida. The move aims to strengthen client collaboration across North America, Latin America, Europe, and beyond, and attract global talent. The company, founded in 2013, will use the new hub for executive leadership and operations.EIN PresswireEMMA International Consulting Group, Inc. Recertified by the Women’s Business Enterprise National CouncilEMMA International Consulting Group, Inc. was recertified as a Women's Business Enterprise and Women Owned Small Business by WBENC. The certification, granted to businesses at least 51% owned by women, reflects the firm's commitment to advancing women-led leadership and inclusive growth. EMMA has maintained this certification since 2020.GlobalfintechseriesEMMA International Now Accepting Cryptocurrency Payments for Consulting ServicesEMMA International Consulting Group, Inc. announced it is now accepting cryptocurrency payments for its consulting services as an optional payment method alongside existing invoicing processes. The move is designed to expand flexible payment options for global clients and facilitate seamless cross-border transactions, reflecting the firm's commitment to operational flexibility and modern business practices. CEO Carmine Jabri stated that this diversification creates greater flexibility for international partners while maintaining the firm's financial discipline and accountability.Lebanon Daily NewsEMMA International Launches AI Solutions for Life Sciences IndustryEMMA International Consulting Group, Inc. announced the launch of AI Solutions, a new consulting service designed to help life sciences organizations deploy artificial intelligence while maintaining regulatory compliance with FDA, EMA, and global health authorities. The solution covers the full AI lifecycle including regulatory strategy, validation, quality system integration, and governance frameworks for organizations in pharmaceutical, biotech, medical device, diagnostics, and digital health sectors. The company positions the service as addressing the challenge of implementing AI responsibly in highly regulated environments where compliance, auditability, and oversight are required.EIN PresswireEMMA International Honored with EurAsia Gulf Excellence Award for Advancing Healthcare Quality StandardsEMMA International Consulting Group, a global quality and regulatory consulting firm for life sciences and healthcare sectors, was awarded the EurAsia Gulf Excellence Award for its contributions to elevating healthcare quality standards and supporting healthcare transformation initiatives throughout the Gulf region. The award recognizes the company's regulatory consulting, healthcare facility development support, and operational improvement programs across the GCC. CEO Dr. Carmine Jabri stated the recognition underscores their commitment to improving healthcare ecosystems through quality, compliance, and operational excellence.EIN PresswireEMMA International Consulting Group, Inc. Launches Financial Services for Life Sciences CompaniesEMMA International Consulting Group, Inc. announced the launch of a new Financial Services offering tailored for life sciences companies, targeting startups and emerging growth firms navigating capital raising and FDA or global regulatory compliance. The service integrates financial strategy with the company's existing regulatory and technical expertise, providing clients with strategic insight on cash flow, capitalization strategy, and operational efficiency aligned with R&D and quality milestones. The announcement was made from the company's Birmingham, Michigan headquarters on October 15, 2025.